After Hours Report

Updated: 02-Mar-26 17:23 ET
MongoDB under heavy pressure following earnings while Life360 pops higher

Stocks had an eventful start to March, with the subdued finishes of the S&P 500 (flat), Nasdaq Composite (+0.4%), and DJIA (-0.2%) betraying the intraday volatility. 

The market opened to considerable losses after a busy weekend of geopolitical headlines that included joint strikes by the U.S. and Israel taking out much of Iran's senior government and military leadership. Iran launched its own strikes on bases across several countries in the region in response, sending oil prices surging and disrupting international travel. 

The energy sector (+2.0%) was the only S&P 500 sector to trade higher for some of the morning and finished as today's top mover. Crude oil futures settled today's session $4.17 higher (+6.2%) at $71.23 per barrel, though they spiked higher after the session's close following a Reuters report that Iran will attack any ship that attempts to traverse the Strait of Hormuz. 

The late-session headline saw stocks retreat from their best levels, which briefly pushed the major averages modestly higher across the board. 

The industrials sector (+1.0%) was another standout today, with its gains largely attributed to the conflict in Iran. Aerospace and defense names such as Axon (AXON 572.02, +29.62, +5.46%), Northrop Grumman (NOC 768.02, +43.64, +6.02%), and RTX (RTX 212.16, +9.54, +4.71%) were among the top performers, helping the iShares DJ Aerospace ETF finish 2.8% higher.

The gains offset weakness across airline names such as United Airlines (UAL 103.21, -3.09, -2.91%) and Delta Air Lines (DAL 64.25, -1.45, -2.21%). 

The top-weighted information technology sector (+0.9%) played a pivotal role in helping the major averages overcome their early losses. The sector opened to modest losses but quickly began to chart a higher course throughout the session until the Strait of Hormuz headlines saw it give back a chunk of its best levels. 

With the U.S. directly involved in conflict in Iran, it is not surprising that Palantir Technologies (PLTR 145.13, +7.94, +5.79%) was a standout today. However, it is worth noting that the broader software space saw solid gains across a number of components today, sending the iShares GS Software ETF 1.5% higher. 

Microsoft (MSFT 398.55, +5.81, +1.48%) posted a nice gain, though NVIDIA (NVDA 182.48, +5.29, +2.99%) was the true "Magnificent Seven" standout after a weekend report from The Wall Street Journal said the company plans to unveil a new chip designed to speed up AI processing, helping the stock recover a chunk of its post-earnings skid.

The real estate sector (+0.3%) also captured a gain, while the seven other S&P 500 sectors finished lower. 

The consumer discretionary sector (-1.1%) was a laggard as a majority of its components traded lower today. Losses were particularly acute across travel names amid the rising fuel costs and geopolitical headlines. Norwegian Cruise Line (NCLH 22.19, -2.60, -10.49%) was among the worst-performing S&P 500 names today after missing revenue expectations and issuing cautious guidance. 

Meanwhile, the defensive consumer staples (-1.4%), health care (-1.0%), and utilities (-0.8%) sectors also lagged amid the rebound across tech names today. 

Outside of the S&P 500, the Russell 2000 (+0.9%) and S&P Mid Cap 400 (+0.8%) outperformed after shrugging off modest early losses of their own. 

Ultimately, today's session underscored the market's resilience to the conflict in Iran, with stocks largely improving throughout the course of the session. President Trump told reporters that the U.S. is ahead of schedule on operations that were initially predicted to last around four to five weeks. JPMorgan Chase CEO Jamie Dimon added commentary of his own in a CNBC interview, stating that if the Iran conflict is not prolonged, there's not going to be a major inflationary impact.

The inflationary effects of higher oil prices could prove to be consequential, particularly as incoming data continue to show firm price pressures beneath the surface. The ISM Manufacturing Index slowed modestly in February but remained in expansion territory, and more notably, the Prices Index accelerated at a faster pace. That pickup is likely to fuel concerns about sticky inflation and reinforce expectations that the Fed will maintain its current policy rate for longer than previously anticipated. In turn, rate-cut expectations have been pushed further out, with the market no longer assigning at least 50% odds to the next cut until the July FOMC meeting, according to the CME FedWatch tool.

U.S. Treasuries began March with a sharp retreat that lifted yields off their lowest levels of the year. The 2-year note yield settled up 11 basis points to 3.49%, and the 10-year note yield settled up nine basis points to 4.05%. 

  • S&P Mid Cap 400: +9.1% YTD
  • Russell 2000: +7.0% YTD
  • DJIA: +1.8% YTD
  • S&P 500: +0.5% YTD
  • Nasdaq Composite: -2.1% YTD

Reviewing today's data:

  • February S&P Global U.S. Manufacturing PMI - Final 51.6; Prior 51.2
  • February ISM Manufacturing Index 52.4% (Briefing.com consensus 52.1%); Prior 52.6%
    • The key takeaway from the report is the faster pace of growth in the Prices Index, as that will fuel concerns about sticky inflation pressure (and the Fed sticking with its current policy rate for longer).

Overseas:

  • Europe: DAX -2.4%, FTSE -1.2%, CAC -2.2%
  • Asia: Nikkei -1.4%, Hang Seng -2.1%, Shanghai+0.5%

Commodities:

  • Crude Oil +4.17 @ 71.23
  • Nat Gas +0.10 @ 2.96
  • Gold +62.80 @ 5311.00
  • Silver -4.25 @ 88.87
  • Copper -0.11 @ 5.95

After-Hours Spotlight:

  • Archer Aviation (ACHR) misses by $0.02, beats on revs...ACHR -4.4%
  • Asana (ASAN) beats by $0.01, reports revs in-line; guides Q1 EPS in-line, revs in-line; guides FY27 EPS in-line, revs in-line...ASAN -0.7%
  • AST SpaceMobile (ASTS) misses by $0.09, beats on revs...ASTS -1.6%
  • Credo Technology Group (CRDO) beats by $0.16, reports revs in-line; guides Q4 revs in-line...CRDO -5.5%
  • Dave, Inc. (DAVE) beats by $1.26, beats on revs; guides FY26 revs above consensus; increases share repurchase authorization to $300 mln...DAVE +8.5%
  • Helios Technologies (HLIO) beats by $0.09, beats on revs; guides Q1 EPS above two analyst estimate, revs above estimate; guides FY26 EPS in-line, revs in-line...HLIO -5.9%
  • Ingram Micro Holding Corp. (INGM) beats by $0.06, beats on revs; guides Q1 EPS in-line, revs in-line...INGM +8.2%
  • LendingTree (TREE) misses by $0.87, beats on revs; guides Q1 revs above consensus; guides FY26 revs above consensus...TREE +13.8%
  • Life360 (LIF) reports Q4 (Dec) results, beats on revs; guides FY26 revs in-line...LIF +16.2%
  • MongoDB (MDB) beats by $0.17, beats on revs; guides Q1 EPS below consensus; guides FY27 EPS above consensus...MDB -24.3%
  • Plug Power (PLUG) misses by $0.53; new CEO assumes role effective today...PLUG +8.3%
  • Surgery Partners (SGRY) misses by $0.18, beats on revs; guides FY26 revs below consensus...SGRY -22.3%

Fair Value for Tuesday, March 3:

  • S&P 500: 6,890
  • Nasdaq 100: 25,029
  • DJIA: 48,951
Today's News Summary:

For a full rundown of today's market and after hours developments, see Live In Play

  • Earnings/Guidance (Full Earnings Calendar):
    • AAON (AAON) misses by $0.06, beats on revs; guides FY26 revs above consensus
    • ADT (ADT) beats by $0.02, misses on revs
    • Belite Bio (BLTE) reports Q4 results
    • Berkshire Hathaway (BRK.B) reports Q4 results
    • Camden Property (CPT) reaffirms FY26 FFO guidance in presentation; provides Q1 operating update
    • Chart Industries (GTLS) reports Q4 (Dec) results, misses on revs; Note: Co previously agreed to be acquired
    • EchoStar (SATS) report FY25 results; beats on revs
    • Healthcare Realty (HR) reaffirms FY26 FFO guidance in investor presentation
    • Humana (HUM) reaffirms FY26 EPS guidance ahead of analyst and investor meetings
    • Kosmos Energy (KOS) reports Q4 results
    • Li Auto (LI) reports February deliveries
    • Lumexa Imaging Holdings (LMRI) issues certain preliminary results for Q4; Issues in-line FY26 revenue guidance
    • NIO (NIO) reports February deliveries
    • Norwegian Cruise Line (NCLH) beats by $0.01, misses on revs
    • Oscar Health (OSCR) will reaffirm the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full-year 2025, dated February 10, 2026
    • RadNet (RDNT) beats by $0.03, beats on revs; guides FY26 revs above consensus
    • Smith & Nephew (SNN) reports Q4 results; provides FY26 outlook
    • Sociedad Quimica y Minera (SQM) misses by $0.16, beats on revs
    • TEGNA (TGNA) beats by $0.07, beats on revs
    • Trump Media & Technology Group (DJT) Reports Full-Year 2025 Results
    • Venture Global (VG) beats by $0.06, reports revs in-line
    • Welltower (WELL) provides FY26 guidance in business update
    • Whirlpool (WHR) provided recalculation of its 2026 ongoing (Non-GAAP) earnings per share guidance
    • XPeng (XPEV) reports February deliveries
    • Zymeworks (ZYME) misses by $0.09, misses on revs
  • General News
    • U.S. & Israel launch “major combat operations” in Iran that are expected to last weeks; Iranian Supreme Leader Ayatollah Ali Khamenei killed; President Trump urges Iranian people to “take over your government” when attacks are finished; S&P futures down 1%; Oil prices up 8%
    • The UK, France, and Germany are considering working with Middle Eastern allies to launch strikes at Iranian missiles, according to WSJ
    • Saudi Arabia and the UAE could start targeting missile and drone launch sites inside Iran, according to WSJ
    • Half of Iranian missile launchers have been destroyed, according to NY Times
    • Commercial ship traffic through the Strait of Hormuz is down 70% amid attacks on Iran, according to NY Times
    • President Trump, in an interview, says the Iran war could last 4-5 weeks, according to NY Times
    • The House will vote this week on a resolution to limit presidential war powers, but the resolution could fail because of some opposition from Democrats, according to Axios
    • Saudi Arabia, Russia, Iraq, UAE, Kuwait, Kazakhstan, Algeria, and Oman adjust production and reaffirm commitment to market stability
    • The U.S. is not planning to release oil from the strategic reserve
    • Qatar stops LNG production at world's top plant after attack - CNBC
    • Airlines cancel numerous flights due to the attack on Iran, according to Reuters
    • The Austin, TX, shooting suspect wore a sweatshirt that said "Property of Allah", according to NBC News
    • The Trump administration wants to delay litigation on tariff refunds by up to four months, according to Bloomberg
    • A judge dismissed a request from the Trump administration to eliminate a student loan repayment plan, according to CNBC
    • UK CMA launches investigation into hotel chains
    • Australia is considering targeting application stores and search engines to enforce age verification law, according to Reuters
    • MLCO Macau Gaming Inspection and Coordination Bureau reported February gross revs +4.5 yr/yr
    • FAA plans to discuss flight restrictions to Chicago O'Hare International Airport to reduce overscheduling and flight delays
    • UAE and Qatar are lobbying allies to persuade President Trump to keep US military operations against Iran short, according to Bloomberg
    • Appeals court sends tariff refund challenge cases to US Court of International Trade
    • Gulf Arab states are facing tough choices including whether or not to go to war with Iran, according to Bloomberg
    • AbbVie's (ABBV) treatment of neuroendocrine carcinoma granted FDA orphan designation
    • Agios Pharma's (AGIO) PYRUKYND (mitapivat) approved for adults with thalassemia in the United Arab Emirates
    • Amazon (AMZN) increases investment in Spain to €33.7 billion to expand data center infrastructure and drive AI innovation across Europe
    • Amazon (AMZN) provides update on operational issue at UAE data center
    • Anthropic: Secretary of War Pete Hegseth issues statement on Anthropic
    • Apollo Global Management (APO): Elliott faces £200 mln exposure after UK lender Market Financial Solutions collapses amid fraud allegations, according to FT
    • Apple's (AAPL) upcoming touch MacBook will be short of an iPad hybrid, according to Bloomberg
    • ASML (ASML) planning to expand chipmaking tools, according to Reuters
    • Astrana Health (ASTH) beats by $0.43, beats on revs; guides Q1 revs in-line; guides FY26 revs in-line; Increases maximum amount of shares of common stock that may be purchased under share repurchase program to $100 mln
    • BAE Systems (BAESY) has introduced Silver Link, a new line of modular, adaptable antenna solutions to support air dominance programs and deliver airborne-assured communications
    • BAE Systems (BAESY) awarded a contract in December 2025 from the Italian Ministry of Defense to modernize the Italian Army's virtual training ecosystem
    • Barclays (BCS) blocked transactions linked to MFS prior to collapse, according to FT
    • Becton Dickinson (BDX) received 510(k) clearance from the FDA for the Surgiphor 1000mL
    • Berkshire Hathaway (BRK.B) CEO Greg Abel letter to shareholders
    • BioMarin Pharmaceutical (BMRN): FDA expands PALYNZIQ approval to adolescents with PKU
    • BlackRock (BLK) aims to sell 11.4% stake in Naturgy, according to Reuters
    • Cameco (CCJ) signs CAD2.6 bln long-term uranium supply deal with India
    • Celldex (CLDX) presents data demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
    • Civista Bancshares (CIVB) announces that Dennis Shaffer, President and Chief Executive Officer of Civista Bancshares, Inc. and Chief Executive Officer of Civista Bank, will retire effective August 28, 2026
    • Cogent Biosciences (COGT) highlights additional data with six Bezuclastinib posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
    • DBV Technologies (DBVT) highlights additional data from successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
    • Delta (DAL) to order 34 Airbus (EADSY) jets, according to Bloomberg
    • Disc Medicine (IRON) begins implementing restructuring plan, includes 20% workforce reduction
    • DraftKings (DKNG) outlines expanded growth strategy and unveils plans to launch super app, “DraftKings Sports & Casino”
    • Eaton (ETN) announces David Foster as Executive Vice President and Chief Financial Officer, effective March 2, 2026
    • Elevance Health (ELV) shares lower by 3% following CMS suspension of enrollment notice
    • Empery Digital (EMPD) confirms receipt of nomination notices from shareholders
    • Endeavour Silver (EXK) announces board and management updates
    • Flex (FLEX) announced the expansion of its strategic collaboration with AMD to manufacture the AMD Instinct platform in the United States
    • GCM Grosvenor & Portal Warehousing (GCMG) form long-term strategic partnership to launch micro-bay industrial property venture
    • Interactive Brokers (IBKR) reports February 2026 metrics - DARTs 21% higher than prior year and 1% lower than prior month
    • Kingsoft Cloud (KC) resolved to revise the annual caps for the comprehensive property services and the property lease services
    • McEwen Mining (MUX): Goliath seeks to extend McEwen-held warrants by six months
    • Merck (MRK) reports KEYTRUDA (pembrolizumab) Plus WELIREG (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)
    • Metropolitan Bank (MCB) has received approval from the U.S. Department of Housing and Urban Development to participate as a lender in the Multifamily Accelerated Processing and LEAN programs
    • Microsoft (MSFT) ticking higher on report it's considering a new AI-loaded software bundle for Microsoft 365, according to Business Insider
    • Norwegian Cruise Line (NCLH): Elliott statement on NCLH
    • NovoCure (NVCR) announces that Japan’s Ministry of Health, Labour and Welfare approved reimbursement for Optune Lua through the country’s National Health Insurance coverage
    • NVIDIA (NVDA) and global telecom leaders commit to Build 6G on Open and Secure AI-Native Platforms
    • Nvidia (NVDA) planning to introduce new chip to speed up artificial intelligence processing, according to WSJ
    • NVIDIA (NVDA) backed 'Reflection AI' start-up valuation discussed in FT
    • OpenAI CEO Sam Altman says company "reached an agreement with the Department of War to deploy our models in their classified network."
    • Orange (ORANY) partners with AST SpaceMobile (ASTS) and Satellite Connect Europe on Direct-to-Device satellite connectivity, starting with demonstrations in Romania
    • Paramount Skydance (PSKY) hires Amazon (AMZN) ad vet Danielle Carney, Tribeca’s Chris Brady to jump-start streaming ads push, according to Business Insider
    • PG&E (PCG) lowers electric prices in March, expects residential customer prices to be lower overall in 2026 than in 2025
    • Pharvaris N.V. (PHVS) data supporting potentially differentiated profile for the on-demand and prophylactic treatment of bradykinin-mediated angioedema presented at AAAAI 2026
    • Pony AI (PONY) reaches Gen-7 robotaxi breakeven in Shenzhen
    • Precision BioSciences (DTIL) announces the achievement of a clinical milestone under its license agreement with TG Therapeutics (TGTX)
    • Qualcomm (QCOM) and Other Industry Leaders Commit to 6G Trajectory Towards Commercialization Starting from 2029 Onwards
    • Roche Hldg (RHHBY): Genentech's Fenebrutinib confirms its potential as first and only BTK Inhibitor for relapsing and primary progressive MS in third positive Phase III study (FENhance 1)
    • Rhythm Pharmaceuticals (RYTM) presents additional data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
    • Rio Tinto (RIO) approves a $473 million mine expansion, according to Bloomberg
    • Sanofi (SNY) secures Japan orphan designation for rilzabrutinib in IgG4-RD
    • Saudi Aramco refinery was hit by a drone, according to Reuters
    • Septerna (SEPN) reports Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
    • Siemens (SIEGY) Canada and Rock Tech sign non-binding Memorandum of Understanding (MoU) laying the foundation for a long-term, multi-phase strategic partnership to develop state-of-the-art lithium conversion capacity
    • Smith & Nephew (SNN) to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN Bioinductive Implant at AAOS 2026
    • Sony (SONY) will fight a $2 billion lawsuit in UK, according to FT
    • Takeda Pharma (TAK) reports FDA accepts rusfertide NDA, grants priority review for polycythemia vera
    • Teledyne (TDY) FLIR Defense signs MoU with STORM Adapt for vehicle-based drone deployment
    • Teradata (TDC) Board approved terms related to Lynrock Cooperation Agreement
    • Thomson Reuters (TRI) to transition CFO role in May
    • Toyota Motor (TM): Elliott Management issues statement on Toyota Industries Corporation
    • uniQure (QURE) reports FDA calls for randomized Phase III trial for uniQure’s AMT-130
    • United Therapeutics (UTHR) announced that its long-term pivotal phase 3 ADVANCE OUTCOMES study met its primary endpoint
    • Upstream Bio (UPB) presents additional analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
    • U.S. GoldMining (USGO) announced initial economic assessment for its 100% owned Whistler Gold-Copper Project
  • Upgrades:
    • Aehr Test Systems (AEHR) upgraded to Outperform from Market Perform at William Blair
    • AppLovin (APP) upgraded to Neutral from Sell at Arete, tgt $340
    • CrowdStrike (CRWD) upgraded to Overweight from Neutral at Piper Sandler, tgt $520
    • Dorman Products (DORM) upgraded to Buy from Hold at Jefferies, tgt $140
    • Dutch Bros (BROS) upgraded to Buy from Neutral at Goldman, tgt $75
    • Eni (E) upgraded to Overweight from Underweight at JPMorgan
    • First American Financial (FAF) upgraded to Overweight from Equal Weight at Stephens, tgt $81
    • Flywire (FLYW) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $17
    • Frontdoor (FTDR) upgraded to Neutral from Sell at Goldman, tgt $67
    • Hyster-Yale Materials Handling (HY) upgraded to Outperform from Market Perform at Northland, tgt $50
    • JetBlue Airways (JBLU) upgraded to Equal Weight from Underweight at Barclays, tgt $7
    • Restaurant Brands International (QSR) upgraded to Buy from Hold at Stifel, tgt $90
    • Restaurant Brands International (QSR) upgraded to Overweight from Neutral at Piper Sandler, tgt $84
    • South Plains Financial (SPFI) upgraded to Overweight from Neutral at Piper Sandler, tgt $48
    • StepStone Group (STEP) upgraded to Overweight from Equal Weight at Barclays, tgt $55
    • TotalEnergies (TTE) upgraded to Overweight from Neutral at JPMorgan
    • Twilio (TWLO) upgraded to Buy from Hold at TD Cowen
    • Zions Bancorporation (ZION) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $75
  • Downgrades:
    • Aardvark Therapeutics (AARD) downgraded to Neutral from Buy at H.C. Wainwright
    • Aardvark Therapeutics (AARD) downgraded to Sector Perform from Outperform at RBC Capital, tgt $6
    • Aardvark Therapeutics (AARD) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $7
    • Aardvark Therapeutics (AARD) downgraded to Hold from Buy at Stifel, tgt $6
    • AZZ Inc. (AZZ) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $132
    • Blue Owl Capital (OWL) downgraded to Equal Weight from Overweight at Barclays, tgt $11
    • Diageo (DEO) downgraded to Hold from Buy at HSBC
    • Fiverr International (FVRR) downgraded to Neutral from Buy at BTIG Research
    • Frontier Group Holdings (ULCC) downgraded to Underweight from Overweight at Barclays, tgt $4
    • GitLab (GTLB) downgraded to Hold from Buy at TD Cowen, tgt $29
    • Novo Nordisk (NVO) downgraded to Neutral from Buy at Goldman, tgt $41
    • PayPal (PYPL) downgraded to Neutral from Outperform at KGI Securities, tgt $55
    • Playtika (PLTK) downgraded to Neutral from Outperform at Wedbush, tgt $3
  • Others:
    • Alibaba Group (BABA) upgraded to Conviction Buy at Goldman
    • Bob's Discount Furniture (BOBS) initiated with a Buy at BofA Securities, tgt $28
    • Bob's Discount Furniture (BOBS) initiated with a Buy at UBS, tgt $27
    • Bob's Discount Furniture (BOBS) initiated with an Outperform at RBC Capital, tgt $26
    • Bob's Discount Furniture (BOBS) initiated with an Overweight at Morgan Stanley, tgt $25.50
    • Bob's Discount Furniture (BOBS) initiated with a Neutral at Robert W. Baird, tgt $22
    • Bob's Discount Furniture (BOBS) initiated with an Overweight at JPMorgan, tgt $29
    • Bob's Discount Furniture (BOBS) initiated with an Overweight at KeyBanc, tgt $28
    • Bob's Discount Furniture (BOBS) initiated with a Neutral at Goldman, tgt $25
    • Eikon Therapeutics (EIKN) initiated with a Buy at BofA Securities, tgt $34
    • Eikon Therapeutics (EIKN) initiated with an Outperform at Mizuho, tgt $26
    • Eikon Therapeutics (EIKN) initiated with an Overweight at JPMorgan, tgt $29
    • Eikon Therapeutics (EIKN) initiated with an Overweight at Morgan Stanley, tgt $32
    • Forgent Power Solutions (FPS) initiated with an Outperform at Oppenheimer, tgt $42
    • Forgent Power Solutions (FPS) initiated with a Buy at TD Cowen, tgt $45
    • Forgent Power Solutions (FPS) initiated with an Outperform at Wolfe Research, tgt $43
    • Forgent Power Solutions (FPS) initiated with an Overweight at JPMorgan, tgt $40
    • Forgent Power Solutions (FPS) initiated with a Buy at Jefferies, tgt $44
    • Forgent Power Solutions (FPS) initiated with an Equal Weight at Morgan Stanley, tgt $38
    • Forgent Power Solutions (FPS) initiated with an Overweight at KeyBanc, tgt $41
    • Forgent Power Solutions (FPS) initiated with an Overweight at Barclays, tgt $44
    • Forgent Power Solutions (FPS) initiated with a Buy at Goldman, tgt $48
    • Genmab (GMAB) initiated with an Overweight at Wells Fargo, tgt $40
    • Netflix (NFLX) reinstated with Overweight from Neutral at JPMorgan, tgt $120
    • Netflix (NFLX) reinstated with an Equal Weight at Barclays, tgt $115
    • NextTrip (NTRP) initiated with a Buy at Ascendiant, tgt $7
    • Regentis Biomaterials (RGNT) initiated with a Buy at ThinkEquity, tgt $10
    • Relmada Therapeutics (RLMD) initiated with a Buy at Lucid Capital, tgt $14
    • Veradermics (MANE) initiated with an Outperform at Leerink, tgt $75
    • Veradermics (MANE) initiated with a Buy at Citigroup, tgt $85
    • Veradermics (MANE) initiated with a Buy at Jefferies, tgt $75
    • Veradermics (MANE) initiated with an Overweight at Cantor Fitzgerald
    • Versant Media Group (VSNT) initiated with a Hold at TD Cowen, tgt $32
  • Econ Data (Tuesday):
    • No U.S. economic data of note. 
  • Earnings:
    • Monday (March 2)
      • Pre-Market: AAON ADT ASTH CRC DAVE NCLH RDNT SEE SATS TPB UNIT VG
      • After-Hours: AES AMRC ACHR ASAN ASTS BBAI CORZ CRDO HLIO INGM TREE LMB LIF MDB PLUG RIOT RGR SGRY ZYME
      Tuesday (March 3)
      • Pre-Market: AZO BBY EVGO KTB MRX ONON SRRK SE SRAD TGT THO VIK
      • After-Hours: BGS BOX CRWD GTLB ROST STAA WBTN
    • Wednesday (March 4)
      • Pre-Market: ANF BBWI BF.B DY GENI JBI EYE STVN WIX
      • After-Hours: AEO BLLN AVGO CBRL GO OKTA RGTI STUB VEEV BULL
    • Thursday (March 5)
      • Pre-Market: ATHM BJ BILI BURL CNQ CIEN GSL JD KR LQDA OLPX SSYS VSCO WLY
      • After-Hours: COO COST GAP GDYN GWRE MRVL MEOH OMDA PTRN IOT SWBI SOBO
    • Friday (March 6)
      • Pre-Market: AQN EMBJ
      • After-Hours: None
Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.